Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Veoneer in connection with its USD 600 million capital raise
Mandate

Vinge advises Veoneer in connection with its USD 600 million capital raise

May 23, 2019 Capital Markets and Public M&A

Veoneer, Inc. (“Veoneer”) has completed a USD 600 million capital raise, consisting of two concurrent offerings of USD 420 million of shares of common stock and USD 180 million aggregate principal amount of convertible senior notes due 2024.

Veoneer is listed on the New York Stock Exchange (NYSE:VNE) and on Nasdaq Stockholm (SSE: VNE SDB). 

Vinge advises Veoneer in relation to Swedish law. Vinge’s team mainly consist of Göran Nyström, Erik Sjöman, Malte Hedlund, Astrid Isberg, Stephanie Stiernstedt, Viktor Bergsten and Anders Sundin Lundberg. Maria Schultzberg advises on tax issues. 
 

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026